Phase 2 trial of first-line combination therapy of cisplatin, pemetrexed and nivolumab in participants with unresectable malignant pleural mesothelioma
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2018
At a glance
- Drugs Cisplatin (Primary) ; Nivolumab (Primary) ; Pemetrexed (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 26 Sep 2018 Trial design of this study presented at the 19th World Conference on Lung Cancer.
- 16 Feb 2018 Status changed from not yet recruiting to recruiting.
- 22 Jan 2018 New trial record